PD25: Bladder Cancer: Basic Research & Pathophysiology II

Podium Session Moderator(s)

• 

  Manish Patel, MD MMed PhD FRACS

  Professor of Urological Oncology
  University of Sydney
• WT

  William Tabayoyong, MD

  Assistant Professor
  University of Rochester Medical Center

Presentations:

• 7:00 AM – 7:10 AM CST

  PD25-01: Macrophage Transcriptomic signature validation in scRNA seq and Overall Survival Differences in Urothelial Carcinoma
  

  Podium Presenter: Laura Bukavina, MD – Cleveland Clinic
• 7:10 AM – 7:20 AM CST

  PD25-02: Intratumoral heterogeneity of molecular subtypes in muscle-invasive bladder cancer – An extensive multi-regional immunohistochemical analysis
  

  Podium Presenter: Gerald Bastian Schulz, MD,FEBU – Department of Urology, LMU Munich
• 7:20 AM – 7:30 AM CST

  PD25-03: Phototherapy with a Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer
  

  Podium Presenter: Vincent D. D'Andrea, MD
• 7:30 AM – 7:40 AM CST

  PD25-04: Application of a multiplex urinalysis test for predicting treatment response in patients with BCG unresponsive bladder cancer: a pilot study
  

  Podium Presenter: Hideki Furuya, PHD – Cedars-Sinai Medical Center
• 7:40 AM – 7:50 AM CST

  PD25-05: Chronic exposure of physiological concentration of Arsenic induced bladder malignancy in preclinical models
  

  Podium Presenter: Hangcheng Fu, MD (he/him/his) – National Cancer Institute
• 7:50 AM – 8:00 AM CST

  PD25-06: Combination Treatment With Intravesical Interferon Gene Therapy and Pan-ErbB Receptor Family Blocker Improves Survival In Mice With Bladder Cancer
  

  Podium Presenter: Akshay Sood, MD – University of Texas MD Anderson Cancer Center
• 8:00 AM – 8:10 AM CST

  PD25-07: Proteomic Profiling of Muscle Invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Reveals Unique Biologic Clusters with Clinical Relevance
  

  Podium Presenter: Alberto Contrerassanz, PHD – Vancouver Prostate Centre
• 8:10 AM – 8:20 AM CST

  PD25-08: The Bladder Tumor Microbiome May Augment Response to BCG in Non-Muscle Invasive Bladder Cancer
  

  Podium Presenter: Zaeem Lone, BA – Roswell Park Comprehensive Cancer Center
• 8:20 AM – 8:30 AM CST

  PD25-09: Tumor associated antigen vaccine enhances anti-tumor effects of immune checkpoint inhibitors against refractory cancers.
  

  Podium Presenter: Shohei Ueda
• 8:30 AM – 8:40 AM CST

  PD25-10: A newly discovered collective migration of urothelial cells: A potential defense mechanism against bladder cancer development
  

  Podium Presenter: Ning Zhang, MD – Kyoto University Hospital
• 8:40 AM – 8:50 AM CST

  PD25-11: Clinical Significance of combinatorial blockade of novel immune checkpoint B7-H4 with PD-L1 in Urothelial Carcinoma of Bladder: A rational therapeutic approach
  

  Podium Presenter: Prabhjot Singh, MD
• 8:50 AM – 9:00 AM CST

  PD25-12: Identification of intratumor pathogens from single-cell RNA sequencing, cellular dysfunction and immune response
  

  Podium Presenter: Laura Bukavina, MD – Cleveland Clinic